Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society

 

Epidemiology Study Group

Main Content

Join now »

Have questions? Contact the MDS Staff Liaison, Sara Villarreal, at svillarreal@movementdisorders.org

About 

The MDS Epidemiology Study group sustains an international network of expert epidemiologists with the aim to conduct and combine studies on disease-modifying factors. The goal is to strengthen the validity of epidemiological studies and derive new biomarkers for movement disorders. These topics are being addressed by a close collaboration between the MDS Epidemiology Study group and geneticists and clinical movement disorders specialists.

Ongoing or upcoming projects of the Study group include the translation and validation of the Parkinson Disease Risk Factor Questionnaire in multiple languages (completed for German, Spanish, and Mandarin-Chinese) and the assessment of psychotropic medication use (i.e. antipsychotics and antidepressants) in patients with Parkinson’s disease. Further, we will perform gene-environment interaction analyses and re-analyses of longitudinal studies with a focus on prodromal non-motor signs and symptoms as outcome.

Need for a Dedicated Study Group in the Field  

With a prevalence of <1%, most movement disorders – including Parkinson’s disease – are comparatively rare. This makes the acquisition of sufficiently sized datasets difficult. As a consequence, individual epidemiologic studies are often underpowered to address the research questions of interest. However, these types of studies are crucial for a broad range of research and clinical care applications. For instance, they aim to derive population-specific incidence rates and prevalences, identify genetic and environmental risk factors, and define the natural history of disease. The MDS Epidemiology Study group was founded to alleviate the current lack of effort invested on conducting and combining appropriately powered epidemiological research. This will be achieved by utilizing the resources available to the international MDS Epidemiology Study Group.

View the group's: 

 

Leadership



Chair: Alastair Noyce



Past Chair: Raymond Lo

clear all

Resource Type

Authoring group

Please wait while we gather your results.

Published Works

Published paper

Surveying Global Availability of Parkinson's Disease Treatment

Read the paper

Resource Type
  • Published paper
Authoring group
  • Epidemiology

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice